-
Cypress Bioscience Inks Deal - Analyst Blog
Monday, August 30, 2010 - 12:45pm | 401Recently, Cypress Bioscience, Inc. (CYPB) announced that it has inked a deal with Marina Biotech, Inc. (MRNA). The deal, which allows Cypress to acquire Marina’s patent rights and technology for autism candidate, carbetocin, is expected to boost the central nervous system pipeline (CNS) at Cypress...
-
8-30-10 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com
Monday, August 30, 2010 - 12:07pm | 3988Stocks are lower as investors await job report Stocks edged lower Monday as investors took a cautious approach to trading before the government’s latest report on the jobs market. Investors have been homing in on employment data as a key way of predicting where the economy is going. Signs of a...
-
A New Audio Interview Featuring Car Charging Group CEO Michael D. Farkas, is now at SmallCapVoice.com
Monday, August 30, 2010 - 9:59am | 2459Aug. 30, 2010 (Business Wire) — SmallCapVoice.com, Inc. announced today that a new audio interview featuring Car Charging Group, Inc. (OTCBB: CCGI) is now available. The interview can be heard at http://smallcapvoice.com/blog/8-24-10-audio-interview-with-car-charging-group-inc-otcbb-ccgi/...
-
BlackRock Bond Trust Raises $1.015 Billion
Monday, August 30, 2010 - 9:07am | 81BlackRock, Inc. (NYSE: BLK) announced today that the BlackRock Build America Bond Trust (NYSE: BBN) has completed pricing its common share initial public offering, which will close on August 31, 2010, raising approximately $1.015 billion. The total amount raised could be increased to approximately...
-
Car Charging Group Paves the Way for Dania Beach With New Electric Vehicle Charging Stations
Friday, August 27, 2010 - 9:43am | 2802MIAMI BEACH, Fla., Aug. 26, 2010 (GLOBE NEWSWIRE) — Car Charging Group, Inc. (OTCBB:CCGI) today announced that it has partnered with the City of Dania Beach Community Redevelopment Agency (CRA) to install and maintain charging stations for electric vehicles at the city’s brand new garage, located...
-
Citi Likes Possible State Street Deal (STT)
Friday, August 27, 2010 - 7:48am | 223Citi Investment Research is out with a research report on talks that State Street (NYSE: STT) may acquire Bank of Ireland Asset Management after a competing bid dropped. It rates shares at Buy/Medium Risk and has a $60 price target. In a note to clients, Citi writes, "We believe the acquisition...
-
The Zacks Small-Cap Profileinclude: Aastrom Biosciences, Aastrom Biosciences, StemCells and International Stem Cell - Press Releases
Thursday, August 26, 2010 - 12:45pm | 2024For Immediate Release Chicago, IL – August 26, 2010 – Today, Zacks.com Small-Cap Institutional Research (SCIR) features the following small-cap profile, including: Aastrom Biosciences (Nasdaq: ASTM), Aastrom Biosciences (Nasdaq: ASTM), StemCells, Inc. (Nasdaq: STEM) and International Stem Cell...
-
8-26-10 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com
Thursday, August 26, 2010 - 11:51am | 4219Stephen Bernard, AP Business Writer Stocks mixed as caution about recovery remains Stocks mixed even as claims for unemployment benefits fall more than expected NEW YORK (AP) — Major stock indexes turned mixed Thursday as a drop in new claims for unemployment benefits wasn’t enough to resolve...
-
Citi Says Take Advantage Of Sell Off In Och Ziff (OZM)
Thursday, August 26, 2010 - 7:40am | 195Citi Investment Research is saying to take advantage of the down spike in shares of Och-Ziff Capital Management Group LLC (NYSE: OZM). It has a Buy/High risk rating and a $21 price target on shares of the publicly traded hedge fund. In a note to clients, Citi writes, "Believe approximate 9%...
-
Citi Sees Valuation Risk At Eaton Vance, $23 Price Target (EV)
Wednesday, August 25, 2010 - 7:44am | 200Citi Investment Research sees no upside in shares of Eaton Vance (NYSE: EV). It has a Sell rating and a $23 price target, far below where shares are currently trading. In a note to investors, Citi writes, "With F3Q10 (July) “dust settled” it appears F4Q10 (Oct) and F2011 consensus estimates remain...
-
Dynegy May Receive Competing Bid (DYN, BX)
Tuesday, August 24, 2010 - 3:48pm | 102Sparkspread.com is out with a report that a private equity outfit is weighing a competing offer for Dynegy (NYSE: DYN). At least one private equity outfit is understood to be weighing a competing offer to acquire Dynegy, following The Blackstone Group's (NYSE: BX) $543 million proposal earlier this...
-
Bulls Pushing Blackstone to New Daily Highs (BX)
Monday, August 23, 2010 - 2:34pm | 210Shares of The Blackstone Group (NYSE: BX) are pushing to new daily highs, currently higher on the session by 5.11%, trading at $10.70. The stock is popping today on word that the company will be partnering with Great Eagle Holdings Ltd. to build 1,000 homes in Dalian in Liaoning, China. The...
-
Campbell Soup May Bid For United Biscuit Business
Monday, August 23, 2010 - 3:56am | 74Campbell Soup (NYSE: CPB) may make an offer of $2.3 billion to acquire the biscuit-making business of U.K.-based United Biscuit the Sunday Times of London reported. The biscuit business accounts for about 75% of United Biscuit's revenue. The Blackstone Group (NYSE: BX) and France-based PAI...
-
Review of the San Francisco Money Show: Recommended Stocks
Saturday, August 21, 2010 - 12:47am | 856I was privileged to give a couple of presentations at the San Francisco Money Show on the stock trading technique of 'buying dividends' during the last couple days, and had a very good turnout and much positive feedback. The show was held at the San Francisco Marriott Marquis Hotel on August 19th...
-
Cephalon Sues Apotex - Analyst Blog
Friday, August 20, 2010 - 3:14pm | 766In a recent filing with the US Securities and Exchange Commission (SEC), Cephalon Inc. (CEPH) announced that it has filed a lawsuit in the US District Court in Delaware against Apotex Corp. and Apotex Inc. Apotex is seeking to launch a generic version of Cephalon’s sleep franchise product, Nuvigil...